Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Sp1 phosphorylation regulates inducible expression of platelet-derived growth factor B-chain gene via atypical protein kinase C-zeta
2001
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Oral Torsemide in Patients With Chronic Congestive Heart Failure: Effects on Body Weight, Edema, and Electrolyte Excretion
1994
Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review
1994
Consensus statement on best practice management regarding the use of intravesical immunotherapy with BCG for bladder cancer
2015
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
Contrast Material-Induced Renal Failure in Patients with Diabetes Mellitus, Renal Insufficiency, or Both
1989 Standout
Diuretic Therapy
1998
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Withdrawal syndrome following cessation of antihypertensive drug therapy
2005
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
Atrial fibrillation and atrial enlargement in patients with mitral stenosis
1987
Myocarditis
2011 Standout
Bladder cancer
2016 Standout
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
The Aquaporins, Blueprints for Cellular Plumbing Systems
1998 StandoutNobel
A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure
1991 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Potential role of potassium as a determinant of morbidity and mortality in patients with systemic hypertension and congestive heart failure
1990
Risks and Benefits of Combined Maze Procedure for Atrial Fibrillation Associated With Organic Heart Disease11It was presented at the 43rd Annual Scientific Session, American College of Cardiology, Atlanta, Georgia, March 1994.
1996
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Mitral valve surgery and atrial fibrillation: is atrial fibrillation surgery also needed?
2000
Polymyositis and dermatomyositis
2003 Standout
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
WR2721 as a modulator of cisplatin-and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach
1993
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Mortality in heart failure: clinical variables of prognostic value.
1987
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
The effect of digoxin on cardiovascular responses to hypoxia and reoxygenation in anesthetized dogs
1982
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Alpha-Adrenergic Receptor Subtypes
1980 StandoutNobel
Studies on digitalis
1977
The clinical significance of inhibition of renal prostaglandin synthesis
1987
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Understanding the Dose-Effect Relationship
1981
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
1994 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure
1998 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Ibuprofen Interferes with the Efficacy of Antihypertensive Drugs
1987
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
2011
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
THE INFLUENCE OF ENDOCRINE HORMONES ON THE AUTONOMIC NERVOUS SYSTEM
1981
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
1980
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure: Basis of a new physiologic approach to control of arrhythmia
1986
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Congestive heart failure in rats is associated with increased expression and targeting of aquaporin-2 water channel in collecting duct
1997
Mechanisms of Membrane-Receptor Regulation
1984 StandoutNobel
Cellular and Molecular Biology of the Aquaporin Water Channels
1999 StandoutNobel
The management of congestive heart failure
1980
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Renal failure following major angiography
1978
The role of vasodilator therapy in heart failure
1977
Intramuscular Injection of Drugs
1976
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Aquaporins in the Kidney: From Molecules to Medicine
2002 StandoutNobel
Adverse Effects of Drugs on Muscle
1982
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Eva Steiness being referenced
Different interactions of indomethacin and sulindac with thiazides in hypertension.
1982
Time course of functional deterioration after coronary artery ligation in rats
1989
Can Bismuth decrease the kidney toxic effect of Cis-platinum?
1989
Spironolactone‐induced changes in digoxin kinetics
1978
Plasma digoxin after parenteral administration Local reaction after intramuscular injection
1974
Reduction of digoxin-induced inotropism during quinidine administration
1980
A Comparative Study of Serum Creatine Phosphokinase (CPK) Activity in Rabbits, Pigs and Humans after Intramuscular Injection of Local Damaging Drugs*
1978
DC-Conversion of Atrial Fibrillation after Mitral Valve Operation.An Analysis of the Long-term Results
1979
BUMETANIDE, A NEW POTENT DIURETIC
1973
Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy.
1976
Incidence of electrolyte disturbances on the effect of digitalis.
1973
Doxorubicin binds in a cooperative manner to myocardial cells
1986
MYOCARDIAL DIGOXIN UPTAKE: DISSOCIATION BETWEEN DIGITALIS‐INDUCED INOTROPISM AND MYOCARDIAL LOSS OF POTASSIUM
1976
Renal handling of iodamide and diatrizoate. Evidence of active tubular secretion of iodamide
1975
Propranolol withdrawal and thyroid hormones in patients with essential hypertension
1978
Renal Tubular Secretion of Digoxin
1974